These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
462 related articles for article (PubMed ID: 26314674)
1. Treatment Strategy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma. Nakamura S; Matsumoto T Gastroenterol Clin North Am; 2015 Sep; 44(3):649-60. PubMed ID: 26314674 [TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori and gastric mucosa-associated lymphoid tissue lymphoma: recent progress in pathogenesis and management. Nakamura S; Matsumoto T World J Gastroenterol; 2013 Dec; 19(45):8181-7. PubMed ID: 24363507 [TBL] [Abstract][Full Text] [Related]
3. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan. Nakamura S; Sugiyama T; Matsumoto T; Iijima K; Ono S; Tajika M; Tari A; Kitadai Y; Matsumoto H; Nagaya T; Kamoshida T; Watanabe N; Chiba T; Origasa H; Asaka M; Gut; 2012 Apr; 61(4):507-13. PubMed ID: 21890816 [TBL] [Abstract][Full Text] [Related]
4. Patients with Helicobacter pylori negative gastric marginal zone b-cell lymphoma (MZBCL) of MALT have a good prognosis. Al-Taie O; Al-Taie E; Fischbach W Z Gastroenterol; 2014 Dec; 52(12):1389-93. PubMed ID: 25474277 [TBL] [Abstract][Full Text] [Related]
7. Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series. Fischbach W; Goebeler ME; Ruskone-Fourmestraux A; Wündisch T; Neubauer A; Raderer M; Savio A; Gut; 2007 Dec; 56(12):1685-7. PubMed ID: 17639089 [TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori and mucosa-associated lymphoid tissue: what's new. Kuo SH; Cheng AL Hematology Am Soc Hematol Educ Program; 2013; 2013():109-17. PubMed ID: 24319171 [TBL] [Abstract][Full Text] [Related]
10. [Prognostic impact of Helicobacter pylori infection and eradication therapy in gastric mucosa-associated lymphoid tissue lymphoma]. Park SH; Chi HS; Park SJ; Jang S; Park CJ; Huh JR Korean J Lab Med; 2010 Dec; 30(6):547-53. PubMed ID: 21157137 [TBL] [Abstract][Full Text] [Related]
11. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status. Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851 [TBL] [Abstract][Full Text] [Related]
13. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment. Nakamura S; Matsumoto T; Suekane H; Nakamura S; Matsumoto H; Esaki M; Yao T; Iida M Cancer; 2005 Aug; 104(3):532-40. PubMed ID: 15937928 [TBL] [Abstract][Full Text] [Related]
14. The role of Helicobacter pylori eradication in the treatment of diffuse large B-cell and marginal zone lymphomas of the stomach. Ferreri AJ; Govi S; Ponzoni M Curr Opin Oncol; 2013 Sep; 25(5):470-9. PubMed ID: 23942292 [TBL] [Abstract][Full Text] [Related]
15. The role of abdominal CT scan as follow-up after complete remission with successful Helicobacter pylori eradication in patients with H. pylori-positive stage I(E1) gastric MALT lymphoma. Choi JY; Lee GH; Ahn JY; Kim MY; Lee JH; Choi KS; Kim DH; Choi KD; Song HJ; Jung HY; Kim JH Helicobacter; 2011 Feb; 16(1):36-41. PubMed ID: 21241410 [TBL] [Abstract][Full Text] [Related]
16. Treatment of gastric mucosa-associated lymphoid tissue lymphoma: Helicobacter pylori eradication and beyond. Montalban C; Norman F Expert Rev Anticancer Ther; 2006 Mar; 6(3):361-71. PubMed ID: 16503853 [TBL] [Abstract][Full Text] [Related]